{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:07:05Z","timestamp":1781712425685,"version":"3.54.5"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233993","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T17:36:55Z","timestamp":1591119415000},"page":"e0233993","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance"],"prefix":"10.1371","volume":"15","author":[{"given":"Rida","family":"Zahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Furqan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-3526","authenticated-orcid":true,"given":"Aziz","family":"Mithani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-4471","authenticated-orcid":true,"given":"Rahman Shah Zaib","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7376-8286","authenticated-orcid":true,"given":"Amir","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"1","key":"pone.0233993.ref001","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"MM Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0233993.ref002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"G Szakacs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"pone.0233993.ref003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Q Wu","year":"2014","journal-title":"Cancer Lett"},{"key":"pone.0233993.ref004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharFmacological aspects of the multidrug transporter","volume":"39","author":"SV Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"pone.0233993.ref005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bjc.1989.282","article-title":"Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69","volume":"60","author":"JG Reeve","year":"1989","journal-title":"British journal of cancer"},{"issue":"11","key":"pone.0233993.ref006","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.leu.2401914","article-title":"Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562\/ADM cells","volume":"14","author":"T Ando","year":"2000","journal-title":"Leukemia"},{"issue":"3","key":"pone.0233993.ref007","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4149\/neo_2012_032","article-title":"Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K\/Akt\/NF-kappaB signaling pathway in a human breast cancer cell line","volume":"59","author":"X Lin","year":"2012","journal-title":"Neoplasma"},{"issue":"1","key":"pone.0233993.ref008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/15384047.2014.987062","article-title":"Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway","volume":"16","author":"T Chen","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"24","key":"pone.0233993.ref009","doi-asserted-by":"crossref","first-page":"39064","DOI":"10.18632\/oncotarget.16589","article-title":"Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60\/ADR cells","volume":"8","author":"Q Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"42","key":"pone.0233993.ref010","doi-asserted-by":"crossref","first-page":"44643","DOI":"10.18632\/oncotarget.5989","article-title":"Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo","volume":"6","author":"J Hu","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"pone.0233993.ref011","first-page":"1439","article-title":"Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein","volume":"286","author":"AE Kim","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"pone.0233993.ref012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/AAC.46.1.160-165.2002","article-title":"Interaction of common azole antifungals with P glycoprotein","volume":"46","author":"EJ Wang","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0233993.ref013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1590\/S1984-82502012000300002","article-title":"Overview of P-glycoprotein inhibitors: a rational outlook","volume":"48","author":"KMR Srivalli","year":"2012","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"key":"pone.0233993.ref014","article-title":"Interactions of patupilone (epothilone B) with multidrug transporter proteins","author":"KM Tanabe","year":"2005","journal-title":"AACR"},{"issue":"12","key":"pone.0233993.ref015","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/0008-5472.CAN-07-0127","article-title":"MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps","volume":"67","author":"S Kasibhatla","year":"2007","journal-title":"Cancer research"},{"issue":"26","key":"pone.0233993.ref016","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1073\/pnas.95.26.15798","article-title":"Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel","volume":"95","author":"T-C Chou","year":"1998","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"pone.0233993.ref017","first-page":"326","volume":"13","author":"Z Binkhathlan","year":"2013","journal-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives"},{"issue":"4","key":"pone.0233993.ref018","first-page":"570","volume":"12","author":"A K Tiwari","year":"2011","journal-title":"Revisiting the ABCs of multidrug resistance in cancer chemotherapy"},{"issue":"3","key":"pone.0233993.ref019","first-page":"815","article-title":"A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma","volume":"75","author":"WS Dalton","year":"1995","journal-title":"A Southwest Oncology Group study"},{"issue":"4","key":"pone.0233993.ref020","first-page":"1224","article-title":"Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia","volume":"100","author":"MR Baer","year":"2002","journal-title":"Cancer and Leukemia Group B Study 9720"},{"issue":"4","key":"pone.0233993.ref021","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cncr.21227","article-title":"Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma","volume":"104","author":"L Pusztai","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"pone.0233993.ref022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells","volume":"6","author":"G Szakacs","year":"2004","journal-title":"Cancer Cell"},{"issue":"3","key":"pone.0233993.ref023","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1087057109359422","article-title":"Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay","volume":"15","author":"M Susa","year":"2010","journal-title":"J Biomol Screen"},{"issue":"4","key":"pone.0233993.ref024","doi-asserted-by":"crossref","first-page":"e60334","DOI":"10.1371\/journal.pone.0060334","article-title":"Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference","volume":"8","author":"MR Ansbro","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"pone.0233993.ref025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1124\/mol.114.095414","article-title":"In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains","volume":"86","author":"FK Brewer","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"1","key":"pone.0233993.ref026","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1038\/s41598-018-21642-0","article-title":"Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance","volume":"8","author":"S Manzoor","year":"2018","journal-title":"Sci Rep"},{"issue":"Pt 3","key":"pone.0233993.ref027","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1107\/S1399004715000978","article-title":"Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein","volume":"71","author":"P Szewczyk","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"2","key":"pone.0233993.ref028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"2 Pt 1","key":"pone.0233993.ref029","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/1078-0432.CCR-06-1424","article-title":"CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo","volume":"13","author":"AN Tse","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"18","key":"pone.0233993.ref030","doi-asserted-by":"crossref","first-page":"15507","DOI":"10.1074\/jbc.M200428200","article-title":"Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae","volume":"277","author":"P Boucher","year":"2002","journal-title":"J Biol Chem"},{"issue":"24","key":"pone.0233993.ref031","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1016\/S0021-9258(18)71707-9","article-title":"Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation","volume":"264","author":"RM Lyall","year":"1989","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0233993.ref032","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1104\/pp.011569","article-title":"Brefeldin A: deciphering an enigmatic inhibitor of secretion","volume":"130","author":"A Nebenfuhr","year":"2002","journal-title":"Plant Physiol"},{"issue":"8","key":"pone.0233993.ref033","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","article-title":"Elesclomol induces cancer cell apoptosis through oxidative stress","volume":"7","author":"JR Kirshner","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"pone.0233993.ref034","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1158\/0008-5472.CAN-10-4433","article-title":"A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients","volume":"71","author":"R Tiedt","year":"2011","journal-title":"Cancer Res"},{"issue":"9","key":"pone.0233993.ref035","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/AEM.61.9.3385-3390.1995","article-title":"Mechanism of pyrithione-induced membrane depolarization in Neurospora crassa","volume":"61","author":"E Ermolayeva","year":"1995","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"pone.0233993.ref036","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"SA Eccles","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"pone.0233993.ref037","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s11095-012-0793-6","article-title":"Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells","volume":"29","author":"M Talekar","year":"2012","journal-title":"Pharm Res"},{"issue":"6","key":"pone.0233993.ref038","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00280-009-1121-7","article-title":"PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK\/c-Jun\/AP-1 and suppressing NF-kappaB","volume":"65","author":"H Bark","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"pone.0233993.ref039","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00280-010-1397-7","article-title":"H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein","volume":"67","author":"N Wei","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"pone.0233993.ref040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1179\/joc.2005.17.1.86","article-title":"Inhibition of P-glycoprotein function and expression by kaempferol and quercetin","volume":"17","author":"P Limtrakul","year":"2005","journal-title":"J Chemother"},{"issue":"1","key":"pone.0233993.ref041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Z Chen","year":"2016","journal-title":"Cancer Lett"},{"issue":"5","key":"pone.0233993.ref042","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1476-5381.2012.01849.x","article-title":"Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein","volume":"166","author":"WJ Zhou","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"5","key":"pone.0233993.ref043","doi-asserted-by":"crossref","first-page":"e00170","DOI":"10.1002\/prp2.170","article-title":"In silico identified targeted inhibitors of P-glycoprotein overcome multidrug resistance in human cancer cells in culture","volume":"3","author":"CA Follit","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"pone.0233993.ref044","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1309\/AC1M-4TY4-U0TN-EN7T","article-title":"Expression of P-glycoprotein in hepatocellular carcinoma: a determinant of chemotherapy response","volume":"113","author":"IO Ng","year":"2000","journal-title":"American journal of clinical pathology"},{"issue":"2","key":"pone.0233993.ref045","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin","volume":"4","author":"E Mechetner","year":"1998","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"pone.0233993.ref046","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2003.11.053","article-title":"Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples","volume":"93","author":"RT Penson","year":"2004","journal-title":"Gynecologic oncology"},{"key":"pone.0233993.ref047","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12885-015-1543-z","article-title":"P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement","volume":"15","author":"HJ Kim","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"pone.0233993.ref048","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2014.12.008","article-title":"Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)","volume":"93","author":"BB Hasinoff","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"pone.0233993.ref049","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3892\/or.2016.4656","article-title":"Effect of brefeldin A and castanospermine on resistant cell lines as supplements in anticancer therapy","volume":"35","author":"K Wojtowicz","year":"2016","journal-title":"Oncol Rep"},{"issue":"5","key":"pone.0233993.ref050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/cgt.2015.15","article-title":"Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines","volume":"22","author":"T Hung","year":"2015","journal-title":"Cancer gene therapy"},{"issue":"4","key":"pone.0233993.ref051","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"K Sawada","year":"2007","journal-title":"Cancer Res"},{"issue":"2\u20133","key":"pone.0233993.ref052","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0925-4439(02)00095-9","article-title":"Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1","volume":"1587","author":"T Hegedus","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"pone.0233993.ref053","first-page":"27","article-title":"P-glycoprotein Inhibition for Optimal Drug Delivery","volume":"7","author":"ML Amin","year":"2013","journal-title":"Drug Target Insights"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T20:56:47Z","timestamp":1722977807000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233993"}},"subtitle":[],"editor":[{"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233993","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}